M&A/IPOs

 

Canadian investment into Bourn Hall

UK-based fertility clinic specialist Bourn Hall has secured "significant investment" from Triangle Capital Corporation, a Canadian-based investment firm.

Metropolis buys big in India, targets further growth

India-based lab group Metropolis Healthcare has bought big in South India, acquiring a network of 31 laboratories and 68 collection centres to its network. The combined entity confirms its position as the second-largest diagnostics company in India and the largest brand in South and West India. Further acquisitions by large Indian diagnostics players are expected.

Appointment of new Artemis CEO lends weight to sale rumours

The CEO of Artemis Group, Germany's second largest ophthalmology chain by revenue, is stepping down from his position as CEO next week to be replaced by the former MD of German rehabilitation specialist Median Kliniken, who is also an ex McKinsey & Company consultant and investment house managing director. A source tells us this is being done in anticipation of a sale.

Biogroup ‘buying’ €100m French lab

France's largest lab group Biogroup is reportedly continuing its consolidation of the French market and in exclusive negotiations to acquire much smaller competitor Oriade Noviale.

Goodgrower buys back 20% Vithas stake, with HM merger “impossible”

Spain's second-largest for-profit hospital chain Vithas will be 100% owned by the founding Gallardo family after their family office Goodgrower agreed to buy the 20% stake held by Criteria Caixa, a bank investment arm. What does it mean for Vithas' M&A plans and the rumoured merger with rival HM Hospitales? We talk to a Spanish advisor.

‘Interest’ in Everlight despite COVID hit to teleradiology

Private equity has reportedly rekindled interest in UK-Australia teleradiology group Everlight Radiology, over a year after owner ICG kickstarted a sales process before COVID hit. But with UK competitor Medica revealing a 20% drop in revenue for the year because of the pandemic, how likely is a sale?

Ramsay Sime Darby targeting $300m spin-off IPO

HBI understands that Malaysian/Indonesian hospital group Ramsay Sime Darby has appointed banks for a $300m IPO. One side of the JV says that expansion in healthcare is a key strategic focus, the other appears notably quiet about its investment in Asia. FY2020 saw profits drop for "the first time in many years" as COVID struck.

Apax Partners France acquires Mentaal Beter

Apax Partners France has acquired Dutch psychiatry group Mentaal Beter. Partner Marc Benatar tells HBI that the group is planning to export its protocolised, pure outpatient model elsewhere in Europe through M&A.

Advent buys from bankrupt Dentix

The largest shareholder in Spain’s dentistry group Vitaldent, Advent International, is acquiring 80 dental clinics from struggling Dentix, and the Dentix brand.

Find Us